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DuringMycobacterium tuberculosis and other respi-
ratory infections, optimal T cell activation requires
pathogen transport from the lung to a local draining
lymph node (LN). However, the infected inflammatory
monocyte-derived dendritic cells (DCs) that trans-
portM. tuberculosis to the local lymph node are rela-
tively inefficient at activating CD4 T cells, possibly
due to bacterial inhibition of antigen presentation.
We found that infected migratory DCs release
M. tuberculosis antigens as soluble, unprocessed
proteins for uptake and presentation by uninfected
resident lymph node DCs. This transfer of bacterial
proteins from migratory to local DCs results in
optimal priming of antigen-specific CD4 T cells,
which are essential in controlling tuberculosis. Addi-
tionally, this mechanism does not involve transfer of
thewhole bacterium and is distinct from apoptosis or
exosome shedding. These findings reveal a mecha-
nism that bypasses pathogen inhibition of antigen
presentation by infected cells and generates CD4
T cell responses that control the infection.
INTRODUCTION
Although activation of naive antigen-specific T cells takes place
in secondary lymphoid tissues such as lymph nodes, most
pathogens are initially localized in peripheral nonlymphoid
tissues, such as the respiratory or gastrointestinal tracts or the
skin. This spatial separation between the location of a pathogen
and the site of T cell activation must be resolved to allow timely
development of adaptive immune responses. While soluble
antigens, certain viruses (Junt et al., 2007), and motile bacteria
(Kastenmu¨ller et al., 2012) can enter lymph nodes by lymphatic
flow, other viral, bacterial, and fungal antigens require transport
from the site of entry in a peripheral tissue to the local lymph
node by migratory dendritic cells (DCs). Once they arrive in a
lymph node, migratory DCs may directly present antigens to
T cells, or they may cooperate with resident lymph node DCs,
which then activate T cells.
Antigen presentation after acquisition from another cell was
first described for an MHC II-restricted antigen acquired byCell HDCs through phagocytosis of antigen-bearing B cells in vitro
(Inaba et al., 1998). In vivo, antigen transfer is best characterized
for MHC I-dependent cross-presentation of viral antigens. After
cutaneous infectionwith herpes simplex virus (HSV), Langerhans
cells and a dermal DC subset transport viral antigens to lymph
nodes, where CD8a+ DCs acquire antigen from them to activate
HSV antigen-specific CD8 T cells (Allan et al., 2003, 2006). Like-
wise, after subcutaneous inoculation with an attenuated vaccine
strain of Blastomyces dermatiditis, migratory DCs transport the
yeast to the local draining lymph node, where they deliver yeast
to resident DCs, which in turn present antigen for CD4 T cell
activation (Ersland et al., 2010). In the respiratory tract, migratory
DCs can directly present influenza virus antigens to CD4 and
CD8 T cells (Ballesteros-Tato et al., 2010; Belz et al., 2004;
Kim and Braciale, 2009; Mount et al., 2008); however, antigen
transfer to lymph node-resident DCs also contributes to CD8
T cell activation (Belz et al., 2004). After respiratory infec-
tion with fungi (Aspergillus or Blastomyces) or a bacterium
(M. tuberculosis), Ly6Chi, CCR2+ inflammatory monocytes or
DCs transport the pathogen from the site of entry in the respira-
tory tract to the local lymph node (Ersland et al., 2010; Hohl et al.,
2009; Samstein et al., 2013; Wu¨thrich et al., 2012). In some, but
not all of the cases examined so far, the migratory cells them-
selves were not able to prime naive CD4 T cells; they required
the cooperation of resident lymph node DCs. This cooperation
clearly includes transfer of pathogen antigens from migratory
to resident DCs, yet the mechanism(s) underlying antigen trans-
fer are not defined, and it is unclear whether antigen transfer
occurs independently of pathogen transfer.
Mycobacterium tuberculosis is an exceptionally successful
bacterial pathogen, due to its ease of aerosol transmission and
its multiple mechanisms for evading and exploiting immune re-
sponses, including inhibition of MHC class II antigen presenta-
tion (Philips and Ernst, 2012). CD4 T cells are essential for control
of tuberculosis in humans (Kwan and Ernst, 2011), mice (Mogues
et al., 2001), cattle (Waters et al., 2011), and nonhuman primates
(Diedrich et al., 2010). Despite their importance in immunity to
tuberculosis, the mechanisms of initial activation of CD4 T cells
remain incompletely understood. While the lung alveoli are the
first sites of implantation of the bacteria, there is considerable
evidence that M. tuberculosis antigen-specific CD4 T cells are
initially activated in the mediastinal lymph node (MDLN), which
drains the lungs. First, activation of naive antigen-specific CD4
T cells occurs in the MDLN, coincides with the appearance of
live M. tuberculosis in the MDLN (Chackerian et al., 2002; Wolfost & Microbe 15, 741–752, June 11, 2014 ª2014 Elsevier Inc. 741
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lungs. The timing of T cell activation in the MDLN depends on
the genetic background of the mice, and earlier T cell activation
in the MDLN is associated with superior control of
M. tuberculosis in the lungs (Chackerian et al., 2002). Second,
CD4 T cell activation in the MDLN depends on transport of
bacteria from the lungs by infected DCs (Khader et al., 2006)
and production of bacterial antigen in the MDLN (Wolf et al.,
2008). Third, a high fraction of the cells that contain bacteria in
the lungs are CD11bhi DCs, and CD11bhi DCs account for nearly
all of the infected cells in the MDLN (Wolf et al., 2007), consistent
with their role in transporting live M. tuberculosis from the
lungs. However, CD11bhi DCs isolated from the MDLN of
M. tuberculosis-infected mice are less efficient at presenting
peptide to antigen-specific CD4 T cells than are other lymph
node DCs (Wolf et al., 2007). Thus, it is unclear whether the
DCs that transport bacteria to the MDLN directly activate
M. tuberculosis-specific naive CD4 T cells or transfer antigen
and/or bacteria to other DC subsets that then prime naive CD4
T cells. This is especially relevant in tuberculosis, since there is
considerable evidence that M. tuberculosis interferes with
MHC class II antigen presentation in the cells that it infects
(reviewed in Baena and Porcelli, 2009). Indeed, a recent study
revealed that after aerosol infection with M. tuberculosis,
CCR2+ inflammatory monocytes, which differentiate into DCs
during or after transit from the lungs to the lymph node, are inca-
pable of activating antigen-specific CD4 T cells, despite their
expression of MHC II (Samstein et al., 2013).
In agreement with the findings of Samstein and colleagues
(Samstein et al., 2013), we report here that infected migratory
DCs activate naive CD4 T cells poorly in mice infected with
M. tuberculosis and that optimal CD4 T cell priming requires
antigen transfer to uninfected lymph node DCs. We found that
transfer of antigen to lymph node DCs occurs without transfer
of the bacteria, involves full-length unprocessed antigen, and
is decreased, not increased, by promoting apoptosis of the
infected cells. Cell-to-cell antigen transfer and cooperation
between migratory and resident lymph node DCs optimize
activation of naive CD4 T cells and may compensate
for M. tuberculosis inhibition of antigen presentation in infected
cells.
RESULTS
Migratory DCs Cooperate with Lymph Node Resident
DCs to Optimize Activation of Naive M. tuberculosis
Antigen-Specific CD4 T Cells
Since migratory CD11c+CD11bhi DCs or CD11c+CD103+ DCs
(Samstein et al., 2013) from M. tuberculosis-infected mice are
less efficient at stimulating CD4 T cells than are other DCs, we
hypothesized that other DCs contribute to stimulating
M. tuberculosis antigen-specific CD4 T cells. To test this hypoth-
esis, we used intratracheal transfer of M. tuberculosis-infected
bone marrow-derived dendritic cells (BMDCs) (Bhatt et al.,
2004; Divangahi et al., 2010; Khader et al., 2006). We initially
validated this method by transferring M. tuberculosis-infected
BMDCs from wild-type mice into wild-type recipients and
assaying proliferation of adoptively transferred TCR transgenic
CD4 T cells specific for aa 240–254 (peptide 25) from742 Cell Host & Microbe 15, 741–752, June 11, 2014 ª2014 ElsevierM. tuberculosis Ag85B, bound to I-Ab (Blomgran and Ernst,
2011; Bold et al., 2011; Olmos et al., 2010; Wolf et al., 2008)
(P25TCR-Tg cells). After transfer of infected BMDCs, a large
fraction of the P25TCR-Tg CD4 T cells proliferated in the
MDLN (Figures 1A and 1B), indicating that intratracheal transfer
of M. tuberculosis-infected BMDCs activates naive P25TCR-Tg
CD4 T cells in vivo. Consistent with our previous finding that
proliferation of naive P25TCR-Tg CD4 cells requires antigen pro-
duction by bacteria in the MDLN (Wolf et al., 2008), intratracheal
transfer of infected BMDCs resulted in the appearance of
M. tuberculosis in the MDLN (Figure 1C). Proliferation was
Ag85B specific, as transfer of BMDCs infected with Ag85B null
M. tuberculosis (H37Rv:DAg85B) (Bold et al., 2011; Wolf et al.,
2008) did not stimulate proliferation (Figures S1A and S1B). Pro-
liferation of P25TCR-Tg CD4 T cells required MHC class II, as
transfer of infected MHC II/ BMDCs into MHC II/ recipients
did not result in T cell proliferation (Figures 1A and 1B). To deter-
mine the contribution of direct presentation of Ag85B by migra-
tory DCs, we transferred M. tuberculosis-infected wild-type
BMDCs into MHC II/ mice, so that only migratory DCs could
present antigen. This resulted in proliferation of P25TCR-Tg
CD4 T cells that was less extensive than when wild-type BMDCs
were transferred into wild-type mice (Figures 1A and 1B). This
implies that MHC II is required on both migratory and resident
lymph node DCs for optimal stimulation of naive CD4 T cells in
response to M. tuberculosis. Notably, transfer of infected MHC
II/ BMDC into wild-type mice, in whom only resident DCs
can present antigen, also resulted in proliferation of P25TCR-
Tg CD4 T cells (Figures 1A and 1B), confirming that resident
lymph node DCs contribute to naive CD4 T cell activation in
the context of tuberculosis.
These results indicate that cooperation between migratory
and lymph node DCs is necessary for optimal activation of naive
antigen-specific CD4 T cells in tuberculosis. The finding that
transfer of MHC II/ DCs into wild-type mice resulted in activa-
tion of naive CD4 T cells suggests that migratory DCs transfer
antigen to lymph node resident DCs during M. tuberculosis
infection.
DC Transport of M. tuberculosis from the Lungs to the
MDLN Is Required for Activation of M. tuberculosis
Antigen-Specific CD4+ T Cells
While the results of the DC transfer experiments are consistent
with transfer of antigen from migratory DCs to other DCs in the
MDLN, they are also consistent with an alternative mechanism:
release of bacteria and/or antigen from cells in the lungs, fol-
lowed by drainage or carriage to the lymph node and uptake
by lymph node DCs. To determine whether chemokine recep-
tor-dependent migration of transferred DCs from the lungs to
the MDLN is essential for activation of naive CD4 T cells, we
initially examined CD4 T cell activation after intratracheal transfer
of M. tuberculosis-infected BMDCs from CCR7/ mice into
wild-type mice. Compared with wild-type DCs, CCR7/ DCs
transported fewer bacteria to the MDLN (Figure 2A) and stimu-
lated less proliferation of P25TCR-Tg CD4 T cells (Figures 2B
and 2C). The finding that the absence of CCR7 did not
completely abrogate trafficking of bacteria or T cell prolifera-
tion is consistent with two possibilities. One is that mechanisms
independent of DC migration contribute to trafficking ofInc.
Figure 1. Migratory and Lymph Node Resi-
dent DCsCollaborate for Optimal Activation
of Naive Antigen-Specific CD4 T Cells in
Tuberculosis
(A–C) Wild-type C57BL/6 or MHC-II/ mice
received CFSE-labeled naive Ag85B-specific
P25TCR-Tg CD4+ T cells followed by intratracheal
transfer of M. tuberculosis-infected wild-type or
MHC-II/ DCs (moi 1:1; 13 106 bacteria/13 106
DCs/ mouse). (A) Proliferation of CFSE-labeled
P25TCR-Tg CD4+ T cells in mediastinal lymph
nodes (MDLNs) of wild-type or MHC-II/ mice
60 hr after intratracheal transfer ofM. tuberculosis-
infected wild-type or MHC-II/ DCs. Flow cy-
tometry plots represent a pool of cells from MDLN
of two mice (three pools from six mice per group).
(B) Quantitation of P25TCR-Tg CD4+ T cells that
have undergone at least one cycle of proliferation
(CFSEdim) in MDLN of the groups of mice shown in
(A). (C) Quantitation of bacteria in MDLN of the
groups of mice shown in (A) and (B). Data are
expressed as mean ± SEM of three pools of mice
(n = 6) per experimental group and represent three
independent experiments. *p < 0.05; **p < 0.01;
***p < 0.001. See also Figure S1.
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mokine receptors other than CCR7 can direct DCmigration from
the lungs to the MDLN, consistent with previously published
findings (Olmos et al., 2010). To distinguish these two possibil-
ities, we treated M. tuberculosis-infected wild-type BMDCs
with pertussis toxin (PTX) prior to transfer. PTX treatment of
infected DCs prior to transfer resulted in retention of bacteria in
the lungs (Figure S2A) and completely blocked the appearance
of bacteria in the MDLN (Figure 2D), indicating that transport of
M. tuberculosis from the lungs to the MDLN depends on G pro-
tein-coupled receptor-dependent migration of infected DCs.
Likewise, PTX treatment of infected BMDCs prior to intratracheal
administration abrogated proliferation of P25TCR-TgCD4 T cells
in the MDLN (Figures 2E and 2F), indicating that migration ofCell Host & Microbe 15, 741–7M. tuberculosis-infected DCs from the
lungs to the MDLN is essential for activa-
tion of naive P25TCR-Tg CD4 T cells.
Although the preceding experiment
indicated that release of bacteria from
donor DCs in the lungs was not respon-
sible for activation of CD4 T cells in the
MDLN, we further evaluated the potential
contribution of free bacteria to naive
CD4 T cell activation. When cell-free
M. tuberculosis was administered intra-
tracheally, up to 5 3 106 cell-free bacte-
ria/mouse (5- to 10-fold more than that
administered with infected BMDCs) failed
to stimulate P25TCR-Tg CD4 T cells in
the MDLN (Figures S2B and S2C). Prolif-
eration of P25TCR-Tg CD4 cells occurred
only after intratracheal inoculation of a
large excess of bacteria (33 107) (Figures
S2B and S2C), indicating that cell-freetranslocation of M. tuberculosis from the lungs to the MDLN
does not account for activation of Ag85B-specific naive CD4
T cells after intratracheal administration of infected DCs. Like-
wise, bacteria appeared in the MDLN only after intratracheal
administration of at least 5 3 106 cell-free M. tuberculosis;
administration of 3 3 107 cell-free bacteria was required to
achieve the number of bacteria in the lymph node (1,200)
(Wolf et al., 2008) required to stimulate naive CD4 T cells
(Figure S2D).
Together, these results indicate that M. tuberculosis reaches
the MDLN from the lungs via DC migration and not through
passive lymphatic drainage of intact bacteria or soluble antigen
secreted by cell-free bacteria. These findings are consistent with
our previously reported findings that activation ofM. tuberculosis52, June 11, 2014 ª2014 Elsevier Inc. 743
Figure 2. DCMigration Is Required for Transport ofM. tuberculosis from the Lungs to the MDLN and Priming of Ag85B-Specific CD4 T Cells
(A) Quantitation of bacteria in the MDLNs of wild-type mice 60 hr after intratracheal transfer of M. tuberculosis-infected wild-type or CCR7/ DCs (moi 0.6:1;
6 3 105 bacteria/1 3 106 DC/mouse).
(B) Proliferation profile of CFSE-labeled P25TCR-Tg CD4+ T cells in MDLNs of the groups of mice shown in (A). Control mice received PBS.
(C) Quantitation of P25TCR-Tg CD4+ T cells that have undergone at least one cycle of proliferation (CFSEdim) in MDLNs of groups of mice shown in (A) and (B).
(D) Quantitation of bacteria in wild-typemice 60 hr after intratracheal transfer of infected wild-type DCs (moi 0.5:1; 53 105 bacteria/13 106 DC/mouse) that were
either mock treated or treated with pertussis toxin (PTX).
(E) Proliferation profile of CFSE-labeled P25TCR-Tg CD4+ T cells in MDLN of the groups of mice shown in (C) and (D). Control mice received PBS. Each CFSE
histogram represents a pool of cells from two mice (three pools from a total of six mice per group).
(F) Quantitation of P25TCR-Tg CD4+ T cells that have undergone at least one cycle of proliferation (CFSEdim) in MDLNs of groups of mice in (D) and (E). Data are
expressed as mean ± SEM of either individual mice (n = 4–5; A–C) or three pools of mice (n = 6; D–F) per experimental group and represent two independent
experiments. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S2.
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Cell-to-Cell Transfer of M. tuberculosis Antigensantigen-specific naive CD4 T cells follows transport of live bac-
teria to the MDLN by DCs after aerosol infection (Wolf et al.,
2008) and are consistent with results obtained after aerosol
infection (Samstein et al., 2013). Additionally, our results suggest
that the cell-to-cell antigen transfer that leads to naive CD4 T cell744 Cell Host & Microbe 15, 741–752, June 11, 2014 ª2014 Elsevieractivation occurs locally in the MDLN after infected migratory
DCs transport bacteria from the lungs. Antigen transfer is effi-
cient, since transfer of as few as 43 104M. tuberculosis-infected
MHC II/ BMDCs stimulated proliferation of P25TCR-Tg CD4
T cells in wild-type recipients (data not shown).Inc.
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Cell-to-Cell Transfer of M. tuberculosis AntigensM. tuberculosis-Infected DC Release Bacterial Antigen
for Uptake and MHC Class II Antigen Presentation
to CD4 T Cells
The finding that transfer of M. tuberculosis-infected, MHC II/
BMDCs into wild-type mice results in activation of naive
P25TCR-Tg cells, and that this requires migration of DCs from
the lungs to the MDLN, suggests that migratory DCs transfer
antigen to resident lymph node DCs. To determine whether
M. tuberculosis-infected DCs release Ag85B for uptake by
other cells, we examined conditioned medium (CM) from
M. tuberculosis-infected BMDCs. CM that was filtered to remove
bacteria and then transferred to uninfected BMDCs stimulated
slight yet significant proliferation of naive P25TCR-Tg CD4
T cells (Figures S3A and S3B) and stimulated robust IFNg
secretion from P25TCR-Tg Th1 effector cells (Figure 3A). Stimu-
lation of P25TCR-Tg Th1 cells by CM-treated BMDC required
infection of the donor DCs by M. tuberculosis that expressed
Ag85B, as BMDCs treated with CM obtained from DCs infected
with Ag85B nullM. tuberculosis (H37Rv:D85B) (Figure 3A) failed
to stimulate P25TCR-Tg Th1 cells.We confirmed the presence of
Ag85B in CMobtained from infected BMDCs by immunoblot and
found that Ag85B in CM is full-length, unprocessed protein (Fig-
ure 3B). We also detected other M. tuberculosis proteins in CM
from infected cells: ESAT-6 and CFP-10 (secreted by the
ESX-1 system) and EsxH (secreted by ESX-3) (Figure 3C). These
data indicate that infected BMDCs release Ag85B and other
antigenic bacterial proteins into the extracellular environment,
where they can be taken up by uninfected DCs and presented
to CD4 T cells.
Antigenic Activity in CM Is Derived from Intracellular
Bacteria
To evaluate the possibility that Ag85B produced by cell-free
bacteria might contribute to the antigenic activity in CM, we
compared the number of bacteria in BMDCs and bacteria in
the medium after 40 hr of infection. More than 95% of the bacte-
ria were associated with the DCs and not free in themedium (Fig-
ure 3D). We also compared antigenic activity in medium from
M. tuberculosis-infected BMDCs and in medium containing an
equivalent number of bacteria in the absence of BMDCs and
found that the latter stimulated < 10% the amount of IFNg from
P25TCR-Tg Th1 cells after addition to uninfected BMDCs (Fig-
ure 3E). Therefore, cell-free bacteria make an insignificant contri-
bution to the Ag85B present in CM fromM. tuberculosis-infected
DCs, and the bulk of Ag85B in the extracellular medium is
derived from bacteria residing in the DCs.
M. tuberculosis-Infected Migratory DCs Transfer
Antigen to Lymph Node Antigen-Presenting Cells In Vivo
The evidence that administration of infected MHC II/ BMDCs
to wild-type mice resulted in activation of naive antigen-specific
CD4 T cells in the MDLN, together with the finding that
M. tuberculosis-infected BMDCs release antigen to extracellular
culture medium in vitro, suggested that infected cells release an-
tigen for uptake and MHC II antigen presentation by other cells.
To determine whetherM. tuberculosis-infected DCs transfer an-
tigen to lymph node resident DCs in vivo, we labeled infected
BMDCs with CFSE and transferred them intratracheally to
wild-type mice. After 60 hr, we isolated MDLN cells from theCell Hrecipient mice and used fluorescent cell sorting to separate the
CFSE+ (donor, infected) BMDCs and the CFSE recipient
MDLN DCs and macrophage subsets (Wolf et al., 2007) (Fig-
ure 4A). Following isolation from the MDLN, the CFSE+ (donor)
cells contained 700 M. tuberculosis cfu/1,000 sorted cells,
while the CFSE (recipient) MDLN cells contained % 0.2 cfu/
1,000 sorted cells (Figure 4B). The CFSE recipient MDLN DCs
and macrophage subsets all activated P25TCR-Tg CD4+ Th1
cells, although the individual subsets varied in their effectiveness
over a 10-fold range (Figure 4C). Likewise, the same recipient cell
subsets activated ESAT-63-15-specific C7 transgenic TCR CD4
Th1 cells with similar relative efficacy (Figure 4E). Since the
only source of antigen for activation of CD4 T cells was from bac-
teria that were administered in the CFSE-labeled BMDCs, the
results indicate that bacterial antigens were transferred from
the infected migratory BMDCs to the resident DCs and macro-
phages in the MDLN. In these experiments, the CFSE+ BMDCs
that were administered intratracheally and recovered from the
MDLN were also able to stimulate P25TCR-Th1 CD4 T cells,
although they were less effective than the 11chi 11bhi subset
(11bhi DCs) of resident lymph node DCs (Figures 4C and 4E).
Addition of exogenous peptide 25 or ESAT-63-15 peptide to
each of the sorted CFSE+ and CFSEmononuclear cell subsets
increased responses of the respective epitope-specific CD4
T cells (Figures 4D and 4F); the relative efficiency of the individual
cell subsets was similar to that observed in the absence of added
peptide. Together, these results indicate that bacterial antigens
are transferred to resident lymph node cells in the absence of
transfer of the bacteria.
Apoptosis and/or Apoptotic Vesicles Do Not Account for
Antigen Transfer during Tuberculosis Infection
To determine whether apoptosis of infected migratory DCs,
followed by uptake of apoptotic cell fragments, accounts for
antigen transfer in vivo, we first used fluorescence microscopy
examination of sorted resident lymph node cells from the exper-
iment described above to detect cell fragments acquired from
the donor CFSE+-infected BMDCs. This revealed that fewer
than 1% of the resident cells contained green fluorescent cell
fragments. This low frequency was similar in all of the cell sub-
sets and did not correlate with the relative ability of the cells in
the individual subsets to activate CD4 T cells (Figures 4C and
4E). To determine whether enhancing apoptosis of infected
migratory DCs would increase antigen transfer and T cell activa-
tion, we compared activation of P25TCR-Tg CD4 cells in wild-
type mice after intratracheal administration of MHC II/BMDCs
infected with H37Rv or with a well-characterized proapoptotic
strain of M. tuberculosis (H37Rv:DnuoG) (Blomgran et al.,
2012; Velmurugan et al., 2007). Administration of BMDCs in-
fected with the proapoptotic NuoG-deficient mutant resulted in
less, not more, proliferation of P25TCR-Tg CD4 T cells than did
administration of BMDCs infected with wild-type bacteria (Fig-
ures 5A–5D). We confirmed that BMDCs infected with NuoG-
deficient M. tuberculosis (H37Rv:DnuoG) underwent enhanced
apoptosis (Figure S4A) and determined that the reduced ability
of BMDCs infected with H37Rv:DnuoG to activate naive CD4
T cells was not due to differences in the number of bacteria in
the transferred cells (Figure S4B) or the number of bacteria in
the MDLN at the time of harvest (Figure S4C). These resultsost & Microbe 15, 741–752, June 11, 2014 ª2014 Elsevier Inc. 745
Figure 3. M. tuberculosis-Infected DCs Release Ag85B for Uptake and Presentation by Uninfected DCs to CD4 T Cells
(A–E) Conditioned medium (CM) was collected 40 hr after infection of DCs withM. tuberculosis (moi = 2), sterile filtered, and added to uninfected DCs along with
Th1-polarized P25TCR-Tg cells. Sixty hours later, IFNgwas quantitated in supernatants. (A) Antigen-dependent IFNg secretion by P25TCR-Tg CD4+ Th1 T cells
cultured with conditioned medium collected from uninfected DCs or DCs infected with either wild-type M. tuberculosis (H37Rv) or Ag85B null M. tuberculosis
(H37Rv:D85B). (B) Immunoblot of Ag85B in conditioned medium fromM. tuberculosis-infected DCs (lane 2) or uninfected DCs (lane 1). (C) Immunoblot showing
presence of ESAT-6, CFP-10, and EsxH in conditioned medium (CM) collected from infected DCs (moi 2) (lane 2) and uninfected DCs (lane 1) after 40 hr. The
infected DCs and uninfected DCs used to generate CM were lysed and probed for actin expression. (D) Quantitation of bacteria in: CM from M. tuberculosis-
infected DCs at time = 0 (CM = 0 hr); CM from infected DCs after 40 hr of culture (CM = 40 hr); or in lysates of DCs infected and cultured for 40 hr (cells = 40 hr). (E)
IFNg secretion by P25 TCR-Tg Th1 CD4+ T cells when cocultured with uninfected DCs in the presence of: CM collected immediately after addition of fresh
medium to M. tuberculosis-infected BMDCs (0 hr); CM collected after 40 hr (40 hr); media from bacteria cultured without cells at 3 3 106/ml or 10 3 106/ml in
BMDC media. Data are expressed as mean ± SEM of three replicates and represent 3–4 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001. See also
Figure S3.
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antigen transfer that promotes priming of naive CD4 T cells.
To further assess the potential contribution of apoptosis to an-
tigen transfer, we compared the antigenic activity in conditioned
medium from cells infected with the proapoptotic NuoG-defi-
cient strain or with wild-type H37Rv. Unfractionated conditioned
medium (CM) from BMDCs infected with H37Rv:DnuoG con-
tained significantly less antigenic activity than did CM from
BMDCs infected with H37Rv (Figures S4D). This suggests that
apoptosis does not account for the release of antigen from in-
fected cells and is consistent with the results of administering
BMDCs infected with proapoptotic or wild-type bacteria on
activation of naive CD4 T cells in vivo (Figure 5). When we
ultracentrifuged CM and examined the antigenic activity in the
supernatants and pellets (containing apoptotic vesicles and exo-
somes), we found that the antigenic activity was most abundant
in the supernatant fraction of CM from cells infected with wild-
type bacteria. Unfractionated CM from cells infected with the
proapoptotic bacteria contained less antigenic activity than
CM from cells infected with wild-type bacteria, and even less
of the antigenic activity from cells infected with proapoptotic
bacteria was present in the supernatant, while a larger propor-
tion appeared in the pellet (Figure S4D). This finding indicates
that Ag85B can be shed in apoptotic vesicles, but that antigen
released in a soluble form accounts for most of the uptake and
presentation to CD4 T cells.
Uninfected Lymph Node Antigen-Presenting Cells
Acquire and Present M. tuberculosis Antigen to CD4 T
Cells after Aerosol Infection
Although our evidence for in vivoM. tuberculosis antigen transfer
from infected to uninfected DCs is persuasive, it depended on
intratracheal administration of dendritic cells. To determine
whether Ag85B is transferred to uninfected lymph node cells
after infection by the natural route (aerosol exposure to a low
bacterial inoculum), we infected mice with GFP-expressing
M. tuberculosis and flow-sorted infected (GFP+) and uninfected
(GFP) live myeloid cells from the MDLNs (Figure 6A). The
GFP fraction was sorted into previously defined CD11c/
CD11b APC subsets (Wolf et al., 2007) and then used to stimu-
late P25TCR-Th1 CD4 T cells ex vivo without addition of exoge-
nous antigen (Figure 6B). This revealed that the uninfected (i.e.,
GFP) MDLN cells activated Ag85B-specific CD4 T cells, and
of these, 11bhi DCs, 11bint DCs, and 11bneg DCs were more
effective at activating P25TCR-Th1 cells than were GFP
11cneg11bhi and 11cneg11bint cells (Figure 6B). These results
confirm the results obtained by intratracheal transfer of infected
BMDCs and indicate that uninfected cells acquire Ag85B in vivo
from infected cells in the MDLN ofM. tuberculosis-infected mice
after low-dose aerosol infection. Acquisition of antigen by unin-
fected cells did not involve transfer of bacteria, as live bacteria
were undetectable in the GFP cells, while bacteria were readily
detected in the sorted GFP+ cells (Figure 6D). Due to the scarcity
of GFP+ cells in the lymph node after aerosol infection, we were
unable to assay their ability to activate antigen-specific CD4
T cells. Following addition of exogenous peptide 25, the GFP
MDLN cell subsets exhibited a similar trend in activating
P25TCR-Th1 cells, albeit with greater effectiveness, implying
that these cells were not saturated with antigen in vivo (Fig-Cell Hure 6C). Together with our previous finding that M. tuberculosis
occupies a small minority of the DCs and macrophages in the
MDLN after aerosol infection (Wolf et al., 2007), these results
suggest that CD4 T cell activation in the MDLN is driven in large
part by uninfected DCs that acquire M. tuberculosis antigens
from infected cells and present them to CD4 T cells in the MDLN.
DISCUSSION
Recent studies of Aspergillus, Blastomyces, andM. tuberculosis
respiratory infections have clearly established that transport of
the pathogen from the lungs to the local draining lymph node
is essential for priming pathogen-specific CD4 T cells (Wolf
et al., 2008) and have indicated that migratory inflammatory
monocytes or DCs cooperate with resident lymph node DCs to
initiate CD4 T cell responses (Ersland et al., 2010; Hohl et al.,
2009; Samstein et al., 2013; Wu¨thrich et al., 2012). However,
the mechanisms of cooperation between migratory and resident
antigen-presenting cells have not been elucidated. Here, we
present evidence that migratory DCs release M. tuberculosis
antigens as soluble undegraded proteins, for uptake and presen-
tation by resident lymph node cells, to optimize priming of anti-
gen-specific CD4 T cells. We also found that antigen release
from infected cells occurs by a mechanism distinct from
apoptosis or exosome shedding. Especially notable is our
finding that antigen transfer occurs in vivo without transfer of
the pathogen. In that regard, the results reported here extend
the recently published findings that inflammatory monocytes,
which acquire DC characteristics during migration, transport
M. tuberculosis from the lungs to the local lymph node, but
must cooperate with classical DCs in the lymph node to prime
ESAT-6-specific CD4 T cells (Samstein et al., 2013). Our results
extend those studies by providing evidence for a mechanism of
antigen export that is independent of apoptosis or exosomes, in-
volves transfer of full-length unprocessed antigen, and occurs
without transfer of the pathogen.
Studies of pathogen-specific T cell priming have indicated that
antigens can be transferred from migratory to resident lymph
node DCs, yet the mechanisms of antigen transfer have received
less attention. One mechanism of antigen transfer involves
apoptosis of pathogen-containing cells, followed by antigen
cross-presentation to prime CD8 T cells (Albert et al., 1998).
Apoptosis and cross-presentation clearly contribute to the prim-
ing of CD8 T cells in the context of vaccination or infection with
M. tuberculosis (Divangahi et al., 2010; Hinchey et al., 2007;
Schaible et al., 2003; Winau et al., 2006). Apoptosis has also
been found to promote priming of CD4 T cells after infection
with M. tuberculosis (Divangahi et al., 2010) or Salmonella (Yrlid
and Wick, 2000). We considered whether apoptosis could
account for antigen transfer in our assays and found that:
(1) antigen did not sediment with apoptotic vesicles; (2)
compared with wild-type bacteria, infection with a proapoptotic
mutant of M. tuberculosis led to a decrease, rather than an in-
crease, in the amount of antigen released; and (3) intratracheal
transfer of MHC II/ BMDCs infected with the proapoptotic
bacterial mutant caused less proliferation of Ag85B-specific
CD4 T cells in vivo. Although exosome shedding also causes
release of antigens from cells infected withmycobacteria (Cheng
and Schorey, 2013; Giri and Schorey, 2008), the bulk of antigenost & Microbe 15, 741–752, June 11, 2014 ª2014 Elsevier Inc. 747
Figure 4. Infected BMDCs Transfer Antigen to Recipient Lymph Node Mononuclear Cells In Vivo
(A–F) Naive wild-type mice received M. tuberculosis-infected, CFSE-labeled BMDCs intratracheally; 48 hr later MDLNs were harvested from 9 mice, pooled,
stained with antibodies to CD11c, CD11b, and Gr-1, and sorted by FACS into subsets that were used to stimulate P25TCR-Tg Th1 CD4 cells. Responses were
quantitated as IFNg secretion. (A) Flow cytometry plots and sorting strategy for CFSE+, M. tuberculosis-infected (donor) BMDCs, and CFSE (recipient) MDLN
cells after gating out Gr-1hiCD11bhi neutrophils. Cells from mice that received unlabeled infected BMDCs were used to set CFSE+ and CFSE gates. (B)
Quantitation of bacteria in FACS-sorted MDLN cell subsets used to stimulate CD4 T cells in (C)–(F). Sorted cells were serially diluted and plated in triplicate, and
colonies were counted 21 days later. (C) IFNg secretion by P25TCR-Tg Th1 CD4 cells (1 APC: 15 T cells) after 4 days of stimulation by sorted CFSE subsets or by
(legend continued on next page)
Cell Host & Microbe
Cell-to-Cell Transfer of M. tuberculosis Antigens
748 Cell Host & Microbe 15, 741–752, June 11, 2014 ª2014 Elsevier Inc.
Figure 5. Increasing Apoptosis of Migratory
DCs Does Not Enhance Antigen-Specific
CD4 T Cell Proliferation In Vivo
(A) Representative FACS plots showing the fre-
quency of adoptively transferred P25TCR-Tg
CD4+ T cells in the MDLN of wild-type C57BL/6
mice, 60 hr after intratracheal transfer of MHC-
II/ DCs infected with H37Rv or H37Rv:DnuoG
(moi 0.5:1; 5 3 105 bacteria/1 3 106 DC/mouse).
(B) Quantitation of total P25TCR-Tg CD4+ T cells in
the MDLNs of the groups of mice shown in (A).
(C) Proliferation profile of CFSE-labeled P25TCR-
Tg CD4+ T cells in the MDLNs of groups of mice
shown in (A) and (B).
(D) Quantitation of P25TCR-Tg CD4+ T cells that
have undergone at least one cycle of proliferation
(CFSEdim) in MDLNs of groups of mice shown in
(A)–(C). Data are mean ± SEM of three pools of
mice (n = 6) per experimental group and represent
two independent experiments. *p < 0.05; **p <
0.01; ***p < 0.001. See also Figure S4.
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sediment exosomes. We also examined the possibility that
‘‘cross-dressing’’ involving transfer of preformedMHC II:peptide
complexes (Wakim and Bevan, 2011) could contribute to our
observations, but were unable to detect evidence of transfer of
MHC II to MHC II/ cells by flow cytometry. While our results
do not exclude contributions of apoptosis or exosome shedding
to release of antigens by infected cells and presentation by
resident DCs, they demonstrate that one or more additional
mechanisms contributes to release of antigen for MHC class II
presentation by resident lymph node DCs.
Although we have not yet determined the precise mechanism
used by M. tuberculosis-infected cells to export soluble anti-
gens, our finding that the antigens are present in conditioned
medium as full-length proteins suggests that they transit through
a nondegradative cellular compartment en route to the extracel-
lular space. Consistent with previous findings that Ag85B can be
detected in intracellular vesicles distinct from phagosomes
(Beatty and Russell, 2000; Harth et al., 1996), our observation
that multiple secreted bacterial proteins are released intact
from infected cells suggests that a vesicular transport mecha-
nism acquires soluble cargo from the phagosome lumen and
transports it to the cell exterior, but more investigation is neces-infected CFSE+ BMDC. (D) Same cells and conditions as in (C), with the addition of Ag85B peptide 25 (1 mg/ml)
Tg Th1 CD4 cells (1 APC: 15 T cells) after 4 days of stimulation by sorted CFSE subsets or by infected CFSE+ B
the addition of ESAT-63-15 peptide (1 mg/ml). Data are expressed as mean ± SEM of replicates and represent t
***p < 0.001.
Cell Host & Microbe 15, 741–7sary to determine whether this is the
dominant mechanism of antigen release.
It is noteworthy that the bacterial proteins
that we found released from infected
dendritic cells are among the immunodo-
minant antigens of M. tuberculosis;
whether release from infected cells and
uptake and efficient presentation by other
cells contributes to their immunodomi-
nance warrants consideration, as it mayguide efforts to stratify M. tuberculosis antigens for vaccine
development. In addition, it will be important to determine
whether antigen release from infected cells is restricted to
secreted bacterial proteins, or whether somatic bacterial pro-
teins are released with similar efficiency.
The observation that pertussis toxin treatment of infected
BMDCs prior to intratracheal administration completely blocked
proliferation of Ag85B-specific CD4 T cells in the lymph node
indicates that antigen transfer occurs after infected cells migrate
to the lymph node, rather than in the lungs prior to migration. If
antigen transfer had occurred in the lungs, endogenous lung
DCs (i.e., not exposed to pertussis toxin) would have transported
it to the lymph node. That antigen transfer occurs after migration
of infected cells to the lymph node likely allows for more efficient
uptake of the antigen that is released, considering the high
density of DCs in the lymph node. That antigen transfer occurs
in the lymph node and not the lungs also helps to explain why
it is advantageous for migratory monocytes or DCs to transport
live bacteria for antigen production in the lymph node, despite
the presence of 100-fold more bacteria in the lungs (Samstein
et al., 2013; Wolf et al., 2008).
Earlier studies revealed release ofmycobacterial lipids from in-
fected macrophages in culture; those lipids include trehalose. (E) IFNg secretion by ESAT-63-15-specific C7TCR-
MDCs. (F) Same cells and conditions as in (E), with
wo independent experiments. *p < 0.05; **p < 0.01;
52, June 11, 2014 ª2014 Elsevier Inc. 749
Figure 6. Transfer of Ag85B without Pathogen Transfer to Resident Antigen-Presenting Cells in the MDLN after Aerosol Infection
(A–D) MDLNs were harvested and pooled from 9–10 mice 15 days post-aerosol infection with GFP-expressing H37Rv (200 cfu/mouse). Lymph node cells were
stained with CD11c, CD11b, and Gr-1-specific antibodies, sorted by FACS, and subsequently used to stimulate P25TCR-Tg Th1 CD4 cells. (A) FACS plot and
sorting strategy for GFP-positive (infected) and GFP-negative (uninfected) MDLN cells based on CD11c/CD11b-defined subsets after neutrophils (Gr-1hi
CD11bhi) were gated out. (B) IFNg secretion by P25TCR-Tg Th1 CD4 cells (1 APC: 15 T cells) after stimulation by GFP-negative (uninfected) sorted CD11c/
CD11b-defined cell subsets. (C) Same cells and conditions as in (B), with the addition of Ag85B peptide 25 (1 mg/ml). (D) Quantitation of bacteria in MDLN cell
subsets used to stimulate CD4 T cells in (B) and (C). Sorted cells were serially diluted and plated in triplicate or quadruplicate; colonies were counted 21 days after
plating. Data are expressed as mean ± SEM of replicates. A similar experiment yielded comparable results. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S5.
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Russell, 2000; Bhatnagar and Schorey, 2007; Bhatnagar et al.,
2007; Harth et al., 1996). If this process also occurs in migratory
DCs and results in transfer of mycobacterial lipids to resident
DCs in the lymph node, it can provide potent adjuvants to
accompany release of the antigenic proteins that we have
detected and further optimize priming of naive M. tuberculosis
antigen-specific CD4 T cells. In light of our findings and the re-
sults of studies revealing release of adjuvant lipids, the evidence
that uninfected cells are the predominant sources of IL-12/23p40
in secondary lymphoid tissues of M. tuberculosis-infected mice
(Rothfuchs et al., 2009) implies that the major steps required
for priming and differentiation of antigen-specific CD4 T cells in
tuberculosis are accomplished by uninfected cells that acquire
signals and antigens from infected cells.
Our finding that M. tuberculosis antigens can be
transferred to lymph node DCs without transfer of the bacteria750 Cell Host & Microbe 15, 741–752, June 11, 2014 ª2014 Elsevieris especially important, since there is considerable evidence
that M. tuberculosis inhibits MHC class II antigen presentation
by infected cells (reviewed in Baena and Porcelli, 2009). While in-
hibiting presentation of antigens by infected cells may provide an
evasion mechanism for the bacteria, antigen transfer to unin-
fected cells provides a mechanism that allows antigen presenta-
tion to naive CD4 T cells to occur without the impediment(s)
imposed by intracellular infection. Since uninfected DCs vastly
outnumber infected DCs in the MDLN (Wolf et al., 2007), we pro-
pose that most or all of the priming of naive M. tuberculosis an-
tigen-specific CD4 T cells is accomplished by uninfected cells
that have acquired antigen by antigen transfer. This model is
supported by the recent report that migratory inflammatory
monocytes or DCs are themselves incapable of priming CD4
T cells duringM. tuberculosis infection; in that system, only clas-
sical DCs were able to perform this function (Samstein et al.,
2013). In this case, the principal, if not the only, role for migratoryInc.
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Cell-to-Cell Transfer of M. tuberculosis Antigensinflammatory monocyte-derived DCs is to transport bacteria
from the lungs to the local lymph node. Thus, transfer of bacterial
lipids and antigenic proteins from infected to uninfected cells can
overcome the processes that M. tuberculosis uses to inhibit
antigen presentation andmanipulate cytokine secretion, thereby
allowing adaptive immune responses to develop and provide
protection to infected individuals.
EXPERIMENTAL PROCEDURES
Mice and Tissue Processing
Mice bred and housed in specific pathogen-free facilities were used according
to procedures approved by the NYU School of Medicine IACUC. Following
infection, MDLN and lungs were harvested, processed, stained, and analyzed
by flow cytometry, and bacteria were quantitated, all as described (Wolf et al.,
2007, 2008).
In Vivo Antigen Transfer Assay
BMDCs were infected with M. tuberculosis, washed, treated with amikacin
(200 mg/ml, 40 min), washed, and administered intratracheally (0.5–1 3 106/
mouse in 100 ml) to mice 1 day after they received CFSE-labeled naive
P25TCR-Tg CD4 cells (1–2 3 106/mouse). Sixty hours after BMDC transfer,
MDLN and lungs were harvested and processed. When required, infected
BMDCs were treated with pertussis toxin (200 ng/ml, 2 hr, 37C) prior to intra-
tracheal transfer.
Generation of Conditioned Media and In Vitro Antigen Transfer
BMDCs (106/ml) were infected overnight with the designated strain of
M. tuberculosis, washed, treated with amikacin, washed twice, and cultured
in fresh BMDC medium (RPMI 1640 with 10% heat-inactivated FBS, 2 mM
L-glutamine, 1 mM sodium pyruvate, 1X b-ME, 10 mM HEPES, and 15 ng/ml
mouse GM-CSF). This medium was then harvested 20–40 hr later, sterile
filtered, and called conditioned medium (CM). The CM was then added to
uninfected BMDCs (2 3 105/well) in 24-well plates along with P25TCR-Tg
RAG-1-deficient CD4+ Th1 effector cells (1–2 3 106/well) for 60 hr, following
which supernatants were collected and quantitated for IFNg by ELISA
(BD Biosciences).
Ag85B Immunoblotting
CM was fractionated using 50K (to deplete albumin) and 3K Centricon filters
(Amicon Ultra; Millipore). The < 50K filtrates were further concentrated using
a 3K filter. Samples were separated on a 10% SDS-PAGE, transferred to
nitrocellulose (BioRad), and probed with rabbit anti-Ag85B (1:1,000) prepared
by immunization with purified recombinant Ag85B (in house) in Titermax Gold
(Sigma). Bound anti-Ag85B was detected using HRP-conjugated goat
anti-rabbit IgG (1:10,000).
Cell Sorting and Stimulation of P25TCR-Tg CD4 T Lymphocytes
MDLN cells from mice infected with GFP-expressing H37Rv were pooled;
stained with CD11c, CD11b, and Gr-1 antibodies as described (Wolf
et al., 2007); and live-sorted using an iCyt Synergy sorter in BSL-3 contain-
ment. Neutrophils were gated out, followed by separation of GFP+ cells
from GFP cells. The GFP set was further sorted based on CD11c and
CD11b expression and cultured (40,000/well) with P25TCR-Tg Th1
effector cells (6 3 105/well) in V-bottom 96-well plates. Supernatants
were collected at day 4 and assayed for IFNg by ELISA. For peptide pre-
sentation, assay conditions were similar except that 1 mg/ml Ag85B peptide
25 was added. An aliquot of sorted cells (GFP+ and GFP) was cultured to
enumerate bacteria. For cell sorting posttransfer of infected CFSE-labeled
DC, the sorting procedure was the same as above where after gating out
neutrophils, CFSE+ subset and CFSE CD11c/CD11b subsets were sorted
and used to stimulate either P25TCR-Tg or C7TCR-Tg Th1 effector cells
(Gallegos et al., 2008) in the absence or presence of (1 mg/ml) respective
peptides. Supernatants were assayed at day 4 for IFNg by ELISA. Aliquots
of sorted CFSE and CFSE+ subsets were plated on 7H11 agar to quanti-
tate bacteria.Cell HStatistical Analysis
Statistical comparisons were performed by unpaired Student’s t test using
Prism 4 for Macintosh (GraphPad, San Diego, CA). P values < 0.05 were
considered significant.
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